← Back to Search

A Study of miRNA 371 in Patients With Germ Cell Tumors

N/A
Waitlist Available
Led By Craig R Nichols
Research Sponsored by SWOG Cancer Research Network
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights
No Placebo-Only Group

Summary

This trial studies whether the blood marker micro ribonucleic acid (miRNA) 371 can predict the chance of cancer returning in patients with germ cell cancers. Studying samples of blood from patients with germ cell cancers in the laboratory may help doctors predict how likely the cancer will come back.

Eligible Conditions
  • Testicular cancer
  • Malignant Neoplasm
  • Germ Cell Tumors
  • Seminoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
To bank blood specimens of patients at low risk and moderate risk of relapse
To estimate positive predictive value of miRNA 371 in early stage testicular seminoma and nonseminoma patients

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Observational (blood collection)Experimental Treatment2 Interventions
Patients undergo collection of blood every 3-6 months for up to 3 years.

Find a Location

Who is running the clinical trial?

SWOG Cancer Research NetworkLead Sponsor
398 Previous Clinical Trials
264,660 Total Patients Enrolled
Southwest Oncology GroupLead Sponsor
388 Previous Clinical Trials
259,245 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,958 Previous Clinical Trials
41,111,624 Total Patients Enrolled
1 Trials studying Germ Cell Tumors
Craig R NicholsPrincipal InvestigatorSWOG Cancer Research Network
~219 spots leftby Jun 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top